Chronically venous ulcer in lower extremities is a permanent and disabling disease. Venous insufficience is the main cause of chronic ulcer. There is a high prevalence and frequency of the disease, primarily among elderly people. Recently, electromagnetic field therapy has been tested on various diseases in musculoskeletal system with a beneficial effect. In recent years, there has been an increasing interest in using electromagnetic field therapy to treat chronically venous ulcer.

The hypothesis of the investigators is that the electronic magnetic field therapy improves the healing process and reduces pain for patients suffering from chronically venous ulcer. The investigators assume that the bioactivity is affected by a cellular response which affects the DNA synthesis, transcription og protein synthesis.

The pain reduction will be measured by VAS and an analysis of the medication between the two group of patients will be carried out in order to measure quality of life, adverse effects, ulceration, granulation tissue etc.

One group of patients receive active devices. Both patients and investigator are blinded.

Other Name: No other names.

Device: Placebo Pulsed Electro-Magnetic Field (PEMF)

One group of patients receive placebo devices. Both patients and investigator are blinded.

Other Name: No other names.

Eligibility

Ages Eligible for Study:

18 Years to 90 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Sampling Method:

Probability Sample

Study Population

Primary care clinic

Criteria

Inclusion Criteria:

Patients who suffer from ulcer in lower extremities

Patients who suffer from venous insufficience detected by duplex scanning or by a pressure on digits > 40 mmHg

Patients with a regular need of compression stockings

Age > 18 years

Exclusion Criteria:

Age < 18 years

Patients who do not read or understand Danish

Patients who suffer from manifest neoplastic disorder

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01561170